[go: up one dir, main page]

SE8400098L - Resinat av en substituerad karbonsyra, forfarande for framstellning derav, anvendning derav och farmaceutiska preparat, som innehaller detta - Google Patents

Resinat av en substituerad karbonsyra, forfarande for framstellning derav, anvendning derav och farmaceutiska preparat, som innehaller detta

Info

Publication number
SE8400098L
SE8400098L SE8400098A SE8400098A SE8400098L SE 8400098 L SE8400098 L SE 8400098L SE 8400098 A SE8400098 A SE 8400098A SE 8400098 A SE8400098 A SE 8400098A SE 8400098 L SE8400098 L SE 8400098L
Authority
SE
Sweden
Prior art keywords
resinates
procedures
preparing
carbonic acid
formula
Prior art date
Application number
SE8400098A
Other languages
English (en)
Other versions
SE8400098D0 (sv
SE457959B (sv
Inventor
S C Khanna
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE8400098D0 publication Critical patent/SE8400098D0/sv
Publication of SE8400098L publication Critical patent/SE8400098L/sv
Publication of SE457959B publication Critical patent/SE457959B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/44—Preparation of metal salts or ammonium salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8400098A 1983-01-12 1984-01-10 Resinat av en substituerad karbonsyra, foerfarande foer framstaellning daerav, anvaendning daerav och farmaceutiska preparat, som innehaaller detta SE457959B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH14783A CH655507B (sv) 1983-01-12 1983-01-12

Publications (3)

Publication Number Publication Date
SE8400098D0 SE8400098D0 (sv) 1984-01-10
SE8400098L true SE8400098L (sv) 1984-07-13
SE457959B SE457959B (sv) 1989-02-13

Family

ID=4180317

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8400098A SE457959B (sv) 1983-01-12 1984-01-10 Resinat av en substituerad karbonsyra, foerfarande foer framstaellning daerav, anvaendning daerav och farmaceutiska preparat, som innehaaller detta

Country Status (41)

Country Link
US (1) US4510128A (sv)
EP (1) EP0122219B1 (sv)
JP (1) JPS59134759A (sv)
KR (1) KR900006747B1 (sv)
AR (1) AR240310A1 (sv)
AT (2) AT391467B (sv)
AU (1) AU570230B2 (sv)
BE (1) BE898649A (sv)
CA (1) CA1218077A (sv)
CH (1) CH655507B (sv)
CS (1) CS269954B2 (sv)
DD (1) DD218373A5 (sv)
DE (2) DE3474152D1 (sv)
DK (1) DK166683B1 (sv)
DZ (1) DZ593A1 (sv)
EG (1) EG16562A (sv)
ES (1) ES528770A0 (sv)
FI (1) FI82682C (sv)
FR (1) FR2542735B1 (sv)
GB (1) GB2134529B (sv)
GR (1) GR79793B (sv)
HK (1) HK90390A (sv)
HU (1) HU190750B (sv)
IE (1) IE56545B1 (sv)
IL (1) IL70660A (sv)
IT (1) IT1177501B (sv)
LU (1) LU85171A1 (sv)
MA (1) MA20000A1 (sv)
MC (1) MC1564A1 (sv)
MT (1) MTP943B (sv)
NL (1) NL8400098A (sv)
NO (1) NO162862C (sv)
NZ (1) NZ206815A (sv)
OA (1) OA07628A (sv)
PH (1) PH21795A (sv)
PL (1) PL142737B1 (sv)
PT (1) PT77932B (sv)
RO (1) RO88481A (sv)
SE (1) SE457959B (sv)
ZA (1) ZA84212B (sv)
ZW (1) ZW484A1 (sv)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.
ES8604955A1 (es) * 1985-11-08 1986-03-16 Covex Sa Procedimiento para la preparacion de resinatos de la (-) eburnamenina-14-(15h)-ona
US5230885A (en) * 1987-12-23 1993-07-27 Smith Kline & French Laboratories Limited Polystyrene anion exchange polymer pharmaceutical composition
AU608114B2 (en) * 1987-12-23 1991-03-21 Smith Kline & French Laboratories Limited Compounds
GB8730010D0 (en) * 1987-12-23 1988-02-03 Smith Kline French Lab Compounds
CH675537A5 (sv) * 1988-03-25 1990-10-15 Ciba Geigy Ag
SE509029C2 (sv) * 1988-08-16 1998-11-30 Ss Pharmaceutical Co Långtidsverkande diklofenak-natriumpreparat
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
DE58903964D1 (de) * 1988-11-10 1993-05-06 Ciba Geigy Ag Fluessige orale formulierung.
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition
GB8911719D0 (en) * 1989-05-22 1989-07-05 Smith Kline French Lab Compounds
GB8913700D0 (en) * 1989-06-14 1989-08-02 Smith Kline French Lab Compounds
GB8913699D0 (en) * 1989-06-14 1989-08-02 Smith Kline French Lab Compounds
US5079001A (en) * 1989-11-03 1992-01-07 Ciba-Geigy Corporation Liquid oral formulation of diclofenac
GB8928278D0 (en) * 1989-12-14 1990-02-21 Smith Kline French Lab Compounds
SE9004129D0 (sv) * 1990-12-21 1990-12-21 Pharmacia Lkb Biotech Anion exchanger
JPH06509099A (ja) * 1991-07-03 1994-10-13 サノ・コーポレーシヨン ジクロフエナツクの経皮デリバリーに対する組成物及び方法
EP1250937B1 (en) * 2001-04-09 2009-05-13 Rohm And Haas Company Controlled dissolution of active ingredients
US20020176842A1 (en) * 2001-04-09 2002-11-28 Lyn Hughes Extended release of active ingredients
US20030180249A1 (en) * 2002-03-18 2003-09-25 Khanna Satish Chandra Dosage forms for hygroscopic active ingredients
RU2221559C1 (ru) * 2002-11-15 2004-01-20 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Препарат диклофенак натрия длительного действия
US20050036977A1 (en) * 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof
WO2006061700A2 (en) * 2004-12-06 2006-06-15 Themis Laboratories Private Limited Rapid disintegrating taste masked compositions and a process for its preparations
ATE536867T1 (de) 2006-03-16 2011-12-15 Tris Pharma Inc Modifizierte freisetzungsformulierungen mit arznei-ion-austausch-harzkomplexen
US7799347B2 (en) 2006-09-07 2010-09-21 Chondrex Inc. Endotoxin-adsorbent for the prevention and treatment of autoimmune diseases
CN107320485A (zh) * 2008-10-02 2017-11-07 匹兹堡大学-属高等教育联邦体系 用于治疗全身性炎症的吸附剂聚合物的施用
AU2011232408B2 (en) 2010-03-24 2015-07-30 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
BR112015003120B1 (pt) 2012-08-15 2022-08-09 Tris Pharma , Inc Tablete mastigável de liberação estendida de metilfenidato e seu uso
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12186296B1 (en) 2016-07-22 2025-01-07 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12478604B1 (en) 2016-07-22 2025-11-25 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US20180263936A1 (en) 2017-03-17 2018-09-20 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
US12458592B1 (en) 2017-09-24 2025-11-04 Tris Pharma, Inc. Extended release amphetamine tablets
BR112021006027A2 (pt) 2018-11-19 2021-06-29 Jazz Pharmaceuticals Ireland Limited formulações de fármaco resistente a álcool
US11400065B2 (en) 2019-03-01 2022-08-02 Flamel Ireland Limited Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
TW202139986A (zh) 2020-02-21 2021-11-01 愛爾蘭商爵士製藥愛爾蘭有限責任公司 治療原發性嗜睡症之方法
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
CN121038779A (zh) 2023-02-03 2025-11-28 特瑞斯制药公司 每晚一次的低钠羟丁酸盐组合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB857193A (en) * 1957-03-14 1960-12-29 Clinical Products Ltd Resin-drug compounds
GB823000A (en) * 1957-10-03 1959-11-04 Clinical Products Ltd Resin-drug compounds
GB869149A (en) * 1958-09-16 1961-05-31 Clinical Products Ltd Liquid pharmaceutical compositions comprising compounds of ion exchange resins and therapeutic substances
US3316282A (en) * 1965-02-08 1967-04-25 Squibb & Sons Inc Anion exchange resin complex of a cycloborate ester of a steroid
NL6817965A (sv) * 1967-12-20 1969-06-24
CH519476A (de) * 1968-03-30 1972-02-29 Hoechst Ag Verfahren zur Herstellung von Salzen von Acylamino-alkylbenzolsulfonyl-harnstoffen mit Anionenaustauschern
US3926864A (en) * 1971-06-21 1975-12-16 Ionics Ion exchange membranes having a macroporous surface area
GB1423694A (en) * 1973-07-10 1976-02-04 Beecham Group Ltd Pharmaceutical compositions
US4058491A (en) * 1975-02-11 1977-11-15 Plastomedical Sciences, Inc. Cationic hydrogels based on heterocyclic N-vinyl monomers
FR2352547A1 (fr) * 1976-05-25 1977-12-23 Viridis Ets Nouvelle resine anionique a action hypocholesterolemiante, son procede de preparation et compositions therapeutiques la contenant
US4217421A (en) * 1977-06-27 1980-08-12 Rohm And Haas Company Anion exchange resins prepared from crosslinked polystyrenesulfonylchloride
US4380590A (en) * 1978-09-19 1983-04-19 Rohm And Haas Company Emulsion copolymer cation exchange resins
IT1106718B (it) * 1978-12-21 1985-11-18 Alfa Farmaceutici Spa Composizioni a base di resine anioniche salificate farmacologicamente attive
US4207399A (en) * 1979-03-14 1980-06-10 Rohm And Haas Company Methylquinoline high polymer based on quaternary ammonium polymers
US4302548A (en) * 1980-05-22 1981-11-24 Rohm And Haas Company Production of ion exchange resins, the resins so produced and ion exchange processes using them

Also Published As

Publication number Publication date
KR840007562A (ko) 1984-12-08
DK11884D0 (da) 1984-01-11
DD218373A5 (de) 1985-02-06
GB8400251D0 (en) 1984-02-08
DE3400491C2 (sv) 1988-11-10
HU190750B (en) 1986-10-28
LU85171A1 (de) 1984-10-24
HUT34151A (en) 1985-02-28
IE56545B1 (en) 1991-08-28
FR2542735B1 (fr) 1986-04-18
HK90390A (en) 1990-11-09
IL70660A (en) 1987-08-31
IT1177501B (it) 1987-08-26
KR900006747B1 (ko) 1990-09-20
CS269954B2 (en) 1990-05-14
SE8400098D0 (sv) 1984-01-10
AR240310A1 (es) 1990-03-30
FR2542735A1 (fr) 1984-09-21
IE840049L (en) 1984-07-12
CA1218077A (en) 1987-02-17
DE3474152D1 (en) 1988-10-27
PL245656A1 (en) 1985-01-02
FI840069A7 (fi) 1984-07-13
FI840069A0 (fi) 1984-01-09
PL142737B1 (en) 1987-11-30
MC1564A1 (fr) 1984-11-12
MA20000A1 (fr) 1984-10-01
EP0122219A2 (de) 1984-10-17
CS17884A2 (en) 1989-10-13
FI82682C (sv) 1991-04-10
RO88481A (ro) 1986-01-30
NO162862C (no) 1990-02-28
JPS59134759A (ja) 1984-08-02
ZA84212B (en) 1984-08-29
NL8400098A (nl) 1984-08-01
NO840090L (no) 1984-07-13
GB2134529B (en) 1986-09-24
PT77932B (en) 1986-07-22
DK11884A (da) 1984-07-13
EP0122219A3 (en) 1985-05-08
EP0122219B1 (de) 1988-09-21
GR79793B (sv) 1984-10-31
IT8447527A0 (it) 1984-01-10
EG16562A (en) 1991-12-30
AT391467B (de) 1990-10-10
MTP943B (en) 1984-06-05
ES8504849A1 (es) 1985-05-01
FI82682B (fi) 1990-12-31
ZW484A1 (en) 1984-08-08
OA07628A (fr) 1985-05-23
DE3400491A1 (de) 1984-07-12
ATE37378T1 (de) 1988-10-15
BE898649A (fr) 1984-07-11
GB2134529A (en) 1984-08-15
US4510128A (en) 1985-04-09
NO162862B (no) 1989-11-20
NZ206815A (en) 1986-08-08
DK166683B1 (da) 1993-06-28
DZ593A1 (fr) 2004-09-13
JPH0257058B2 (sv) 1990-12-03
IT8447527A1 (it) 1985-07-10
ATA784A (de) 1990-04-15
AU2323084A (en) 1984-07-19
ES528770A0 (es) 1985-05-01
AU570230B2 (en) 1988-03-10
SE457959B (sv) 1989-02-13
PH21795A (en) 1988-02-29
PT77932A (en) 1984-02-01
CH655507B (sv) 1986-04-30
IL70660A0 (en) 1984-04-30

Similar Documents

Publication Publication Date Title
SE8400098L (sv) Resinat av en substituerad karbonsyra, forfarande for framstellning derav, anvendning derav och farmaceutiska preparat, som innehaller detta
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
NO883229D0 (no) Nye benzimidazolderivater, fremgangsmaate for deres fremstilling og farmasoeytisk preparat inneholdende slike derivater.
DE2962619D1 (en) 1-(3-mercapto-2-methylpropanoyl)prolyl amino acid derivatives and salts thereof, processes for their preparation, and pharmaceutical compositions containing such compounds
DE2961284D1 (en) Tetrahydropyridinyl indole derivatives and their salts, process for their preparation, their use as medicines and pharmaceutical compositions containing them
HU9400430D0 (en) New pyrazine derivatives, their preparation and pharmaceutical compositions containing them
ATE10368T1 (de) Uracilderivate, verfahren zu ihrer herstellung und eine diese enthaltende pharmazeutische zubereitung.
EP0369744A3 (en) Xanthine derivatives, process for their preparation and pharmaceutical compositions
BE881631A (fr) Nouveaux derives de l'oxoimidazoquinoxaline et leurs sels, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
DE3061693D1 (en) Secondary amines, their preparation and use in pharmaceutical compositions
BE878916A (fr) Nouveaux derives du 3-aminoethyl phenol et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
IT1232303B (it) Composti di diammina e loro sali, procedimenti per la loro preparazio ne e composizioni farmaceutiche contenenti detti composti e i loro sa li
FR2432520A1 (fr) Nouvelles imidazoquinoxalines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
DK408083A (da) Isoquinolinderivater, deres fremstilling og anvendelse
BE885605A (fr) Derives d'acide benzo(ij)quinolizine-carboxylique-2, utiles notamment comme medicaments antimicrobiens, procede de leur preparation et compositions therapeutiques et formes pharmaceutiques les contenant
CS369691A3 (en) Pharmaceutical preparations containing functional vinyl azoles, the use of said vinyl azoles for medicaments preparation, the vinyl azoles per se as well as process for preparing said vinyl azoles
IE873212L (en) Medicaments based on derivatives of 3,4-di-phenylpiperidine,¹the use of the derivatives as medicaments, and novel¹3,4-diphenylpiperidine derivatives and a process for the¹preparation therefor
DE2860796D1 (en) Tantomeric arylaminoimidazoline derivatives, their preparation and pharmaceutical formulations for analgetic application containing them
AU8029091A (en) Disubstituted polymethyleneimines, a process for the preparation thereof, and pharmaceutical compositions containing them
ATE7911T1 (de) Pharmazeutisch zulassbare salze von 4'-(9acridinylamino)methansulfon-m-anisid, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
IT8349055A0 (it) B-osso-l-carbammoil-pirrolpropionitrile, procedimento per la loro produzione, preparati farmaceutici con tenenti questi composti, nonche' il loro impiego terapeutico
AU6492890A (en) Furosemide salts, preparation process, use as medicaments and pharmaceutical compositions containing them
PT86920A (pt) Process for the preparation of a hypocholesterolaemic gel formulation containing a pharmaceutically acceptable non-digestible anion exchangeresin
ES8707529A1 (es) Procedimiento para preparar compuestos de imidazo-isoquinoleina y de imidazo-tienopiridina
ZA793541B (en) Substituted 2-phenylamino-imidazoline-(2)derivatives and their acid addition salts,processes for their preparation and pharmaceutical compositions containing these compounds

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8400098-3

Effective date: 19940810

Format of ref document f/p: F